Table 2. Clinical characteristics of healthy controls and PCOS patients in the second cohort (Control n = 49, PCOS n = 67).
| Variables | Control | PCOS |
| Age (year) | 28.0±0.2 | 28.0±0.1 |
| BMI (kg/m2) | 20.8±0.2 | 22.2±0.3a |
| LH (mIU/mL) | 3.1±0.1 | 5.3±0.5a |
| FSH (mIU/mL) | 6.9±0.3 | 5.9±0.2a |
| E2 (pg/mL) | 44.4±4.7 | 48.0±3.6a |
| PRL (ng/mL) | 26.2±1.6 | 26.0±2.1 |
| P (ng/mL) | 1.2±0.2 | 1.5±0.4 |
| T (ng/mL) | 0.3±0.0 | 0.4±0.0a |
Data represent the mean ± SEM;
BMI: body mass index, LH: luteinizing hormone, FSH: follicle stimulating hormone, E2: estradiol, PRL: prolactin, P: progesterone, T: testosterone;
a
p<0.001 compared with the control group, p values are determined by Student’s t-test.